logo
logo

Ibex Raises $55 Million In Series C Funding To Drive Global Adoption Of Ai For Cancer Diagnosis

Ibex Raises $55 Million In Series C Funding To Drive Global Adoption Of Ai For Cancer Diagnosis

09/06/23, 11:04 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/IL.svgtel aviv
Money raised
$55 million
Industry
artificial intelligence
biotechnology
health care
information technology
software
health diagnostics
machine learning
Round Type
series c
Investors
Dell Technologies Capital, Planven Entrepreneur Ventures, A Moon, Octopus Ventures, Sienna Venture Capital, 83 North
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100 million since Ibex's inception in 2016.

Company Info

Company
Ibex Medical Analytics
Location
tel aviv, tel-aviv district, israel
Additional Info
Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity. We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Our Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Galen is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: transform cancer diagnosis with AI and improve patient care. If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to make real impact – we want to hear from you.

Related People